Publications

Toxicity and Normal Tissue Complication Probability (NTCP) Analysis

Liang Y, Kim GY, Pawlicki T, Mundt AJ, Mell LK. Feasibility study on dosimetry verification of volumetric- modulated arc therapy-based total marrow irradiation. J Appl Clin Med Phys 2013;14:3852.

Rose BS, Liang Y, Lau SK, Jensen LG, Yashar CM, Hoh CK, Mell LK. Correlation between radiation dose to 18F-FDG-PET defined active bone marrow sub-regions and acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2012;83:1185-91.

Simpson DR, Song WY, Rose BS, Nath SK, Yashar CM, Mundt AJ, Mell LK. Normal tissue complication probability analysis of acute gastrointestinal toxicity in cervical cancer patients undergoing intensity modulated radiation therapy and concurrent cisplatin. Int J Radiat Oncol Biol Phys. 2012;83:e81-6.

Moiseenko V, Song WY, Mell LK, Bhandare N. A comparison of dose-response characteristics of four NTCP models using outcomes of radiation-induced optic neuropathy and retinopathy. Radiat Oncol. 2011;6:61.

Rose BS, Aydogan B, Liang Y, Yeginer M, Hasselle MD, Dandekar V, Bafana R, Yashar CM, Mundt AJ, Roeske JC, Mell LK. Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2011;79:800-7.

Song WY, Huh SN, Liang Y, White G, Nichols RC, Watkins WT, Mundt AJ, Mell LK. Dosimetric comparison study between intensity modulated radiation therapy and three-dimensional conformal proton therapy for treatment of cervical cancer. J Appl Clin Med Phys. 2010;11:83-92.

Aljarrah K, Pawlicki T, Niemierko A, Mell LK, Jiang SB. A clinical study of MLC-based IMRT lung dose calculation accuracy on plan evaluation parameters. J Cancer Sci Ther. 2010;74-81.

Liang Y, Messer K, Rose BS, Lewis JH, Jiang SB, Yashar CM, Mundt AJ, Mell LK. The impact of bone marrow radiation dose on acute hematologic toxicity in cervical cancer: principal component analysis on high dimensional data. Int J Radiat Oncol Biol Phys. 2010; 78:912-9.

Devisetty K, Mell LK, Salama JK, et al. A multi-institutional acute gastrointestinal toxicity analysis of anal cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemotherapy. Radiother Oncol. 2009;93:298-301.

Salama JK, Stenson KM, List MA, Mell LK, et al. Characteristics associated with swallowing changes following concurrent chemoradiotherapy in head and neck cancer patients. Arch Otolaryngol Head Neck Surg. 2008;134:1060-5.

Mell LK, Movsas B. Pharmacologic normal tissue protection in clinical radiation oncology: focus on amifostine. Expert Opin Drug Metab Toxicol. 2008;4:1341-1350

Mell LK, Tiryaki H, Ahn KH, et al.  Dosimetric comparison of bone marrow-sparing intensity modulated radiation therapy versus conventional techniques for the treatment of cervical cancer. Int J Radiat Oncol Biol Phys. 2008;71:1504-10.

Mell LK, Schomas DA, Salama JK, et al.  Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2008;70:1431-7.

Mell LK, Malik R, Komaki R, et al. The effect of amifostine on response rates in locally advanced non-small cell lung cancer patients treated on randomized trials: a meta-analysis. Int J Radiat Oncol Biol Phys. 2007;68:111-8.

Mell LK, Kochanski J, Roeske JC, et al.  Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy. Int J Radiat Oncol Biol Phys. 2006;66:1356-65.

Aydogan B, Mundt AJ, Smith B, Mell LK, et al. A dosimetric analysis of intensity modulated radiation therapy (IMRT) as an alternative to adjuvant high dose rate (HDR) brachytherapy in early endometrial cancer patients. Int J Radiat Oncol Biol Phys. 2006;65:266-73.

Schroder M, Mell LK, Hurteau JA, et al.  Clinical trial of Eros therapy for the treatment of sexual dysfunction in irradiated cervical cancer patients. Int J Radiat Oncol Biol Phys. 2005;61:1078-86.

Roeske JC, Bonta D, Mell LK, Lujan AE, Mundt AJ. A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy. Radiother Oncol. 2003;69:201-7.

Mundt AJ, Mell LK, Roeske JC.  Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. Int J Radiat Oncol Biol Phys. 2003;56:1354-60. 

 

Imaging and Image-Guided Radiation Therapy

MacEwan IJ, Glembotski NE, D’Lima D, Bae W, Masuda K, Rashidi HH, Mell LK, Bydder M. Proton density water fraction as a biomarker of bone marrow cellularity: validation in ex vivo spine specimens. Magn Reson Imaging 2014;32(9):1097-101

Carmona R, Bydder M, Pritz J, Gulaya S, Vaida F, Bydder G, Mell LK. Fat composition changes in bone marrow during chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 2014; 2014;90:155-63

Call JA, Prendergast BM, Jensen LG, Ord CB, Goodman KA, Jacob R, Mell LK, et al. Intensity-modulated radiation therapy for anal cancer: results from a multi-institutional retrospective cohort study. Am J Clin Oncol 2014; in press. PMID: 24401669

Li N, Zarepisheh M, Uribe-Sanchez A, Moore K, Tian Z, Zhen X, Graves YJ, Gautier Q, Mell L, et al. Automatic treatment plan re-optimization for adaptive radiotherapy guided with the initial plan DVHs. Phys Med Biol 2013;58:8725-8738.

Gu X, Dong B, Wang J, Yordy J, Mell LK, et al. A contour-guided deformable image registration algorithm for adaptive radiotherapy. Phys Med Biol 2013;58:1889-1901.

Pan H, Rose BS, Simpson DR, Mell LK, Mundt AJ, Lawson JD. Clinical practice patterns of lung stereotactic body radiation therapy in the United States: a secondary analysis. Am J Clin Oncol 2013;36:269-72.

Jensen LG, Hasselle MD, Rose BS, Nath SK, Hasan Y, Scanderbeg D, Yashar CM, Mundt AJ, Mell LK. Outcomes for cervical cancer patients treated with extended field intensity-modulated radiation therapy and concurrent cisplatin. Int J Gynecol Cancer. 2013;23:119 25.

Mundt AJ, Yashar C, Mell L, Mayr N, Milosevic M. Oncology scan - gynecological cancers: new treatments, old treatments, imaging, and meta-analyses. Int J Radiat Oncol Biol Phys 2013;86:207-10.

Liang Y, Bydder M, Yashar CM, Rose BS, Cornell M, Hoh CK, Lawson JD, Einck J, Saenz C, Fanta P, Mundt AJ, Bydder GM, Mell LK. Prospective study of functional bone marrow-sparing intensity modulated radiotherapy with concurrent chemotherapy for pelvic malignancies. Int J Radiat Oncol Biol Phys. 2013; 85:406-14.

Park JC, Park SH, Kim JH, Yoon SM, Song SY, Liu Z, Song B, Kauweloa K, Webster MJ, Sandhu AP, Mell LK, et al. Liver motion during cone beam computed tomography guided stereotactic body radiation therapy. Med Phys 2012;39:6431-42.

Khan A, Jensen LG, Sun S, Song WY, Yashar CM, Mundt AJ, Zhang F, Jiang SB, Mell LK. Optimized planning target volume for intact cervical cancer. Int J Radiat Oncol Biol Phys. 2012;83:1500-5.

Mell LK. Intensity modulated radiation therapy for gynecologic malignancies: a testable hypothesis. Int J Radiat Oncol Biol Phys 2012;84:566-8.

Pan H, Simpson DR, Mell LK, Mundt AJ, Lawson JD. A survey of stereotactic body radiotherapy use in the United States. Cancer. 2011;117:4566-72

Hasselle MD, Rose BS, Kochanski JD, Nath SK, Bafana R, Yashar CM, Hasan Y, Roeske JC, Mundt AJ, Mell LK. Clinical outcomes of intensity modulated radiation therapy for carcinoma of the cervix: a multi-institutional analysis. Int J Radiat Oncol Biol Phys. 2011;80:1436-45.

Tyagi N, Lewis JH, Yashar CM, Vo D, Jiang SB, Mundt AJ, Mell LK. Daily online cone beam computed tomography to assess inter-fraction motion in patients with intact cervical cancer. Int J Radiat Oncol Biol Phys. 2011;80:273-80.

Lim K, Small W Jr, Portelance L, Creutzberg C, Jürgenliemk-Schulz IM, Mundt A, Mell LK, et al. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the intact cervix. Int J Radiat Oncol Biol Phys. 2011;79:348-55

Manoj S, Mell LK. Advanced radiation therapy techniques for head and neck cancer. Support for People with Oral and Head and Neck Cancer Newsletter. 2010;19(7):1-4.

Simpson DR, Lawson JD, Nath SK, Rose BS, Mundt AJ, Mell LK. A survey of image-guided radiation therapy use in the United States. Cancer. 2010;116:3953-60

Simpson DR, Lawson JD, Nath SK, Rose BS, Mundt AJ, Mell LK. Utilization of advanced imaging technologies for target delineation in radiation oncology. J Am Coll Radiol. 2009;6:876-83.

Al-Hallaq A, Mell LK, Bradley J, et al. Magnetic resonance imaging identifies multifocal and multicentric disease in breast cancer patients who are eligible for partial breast irradiation. Cancer. 2008;113:2408‑14.

Mell LK, Mundt AJ.  Intensity modulated radiation therapy in gynecologic cancers: growing support, growing acceptance.  Cancer Journal 2008; 14:198-9.

Small W, Mell LK, Anderson P, et al. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer. Int J Radiat Oncol Biol Phys. 2008;71:428-34.

Mell LK, Mehrotra A, Mundt AJ. Intensity modulated radiation therapy use in the United States, 2004. Cancer. 2005;104:1296-303.

Schomas DA, Milano M, Roeske JC, Mell LK, Mundt AJ. Intensity modulated radiation therapy and the internet: evaluating the content and accuracy of patient-oriented information. Cancer. 2004;101:412-20.

Mell LK, Roeske JC, Mundt AJ.  A survey of the use of intensity modulated radiation therapy (IMRT) in the United States. Cancer. 2003;98:204-11.  

 

 Outcomes, Biomarkers and Health Disparities

Mell LK, Zietman AL. Introducing prospective manuscript review to address publication bias. Int J Radiat Oncol Biol Phys 2014;90:729-32.

Xu B, Boero I, Le QT, Sanghvi PR, Mell LK, Murphy JD. Aspiration pneumonia after concurrent chemoradiotherapy for head-and-neck cancer. Cancer. In press. PMID: 25537836

Simpson DR, Mell LK, Cohen EE. Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of the head and neck. Oral Oncology. In press. PMID: 25532816

Spiotto MT, Cao H, Mell L, Toback FG. Angiotensin-converting enzyme inhibitors predict acute kidney injury during chemoradiation for head and neck cancer. Anticancer Drugs 2014 Dec 6. In press. PMID: 25486599

Mell LK, Zakeri K, Rose BS. On lumping, splitting, and the ‘nosology’ of clinical trial populations and endpoints. J Clin Oncol 2014;32:1089-90.

Wong J, Xu B, Yeung HN, Roeland EJ, Martinez ME, Le QT, Mell LK, Murphy JD. Age disparity in palliative radiotherapy among patients with advanced cancer. Int J Radiat Oncol Biol Phys 2014;90:224‑30.

Pfister DG, Spencer S, Brizel DM, …, Mell LK, et al. Head and neck cancers, version 2.2014. J Natl Compr Canc Netw 2014;12:1454-87.

Yeung HN, Mitchell WM, Roeland EJ, Xu B, Mell LK, et al. Palliative radiation before hospice: the long and the short of it. J Pain Symptom Manage 2014;48(6):1070-9

Carmona R, Gulaya S, Murphy JD, Rose BS, Wu J, Noticewala S, McHale MT, Yashar CM, Vaida F, Mell LK. Validated competing event model in the stage I-II endometrial cancer population. Int J Radiat Oncol Biol Phys 2014;89:888-98.

Zakeri K, Macewan I, Vazirnia A, Cohen EW, Spiotto MT, Haraf DJ, Vokes EE, Weichselbaum RR, Mell LK.  Race and competing mortality in advanced head and neck cancer. Oral Oncology 2014;50:40‑4.

Simpson DR, Martinez E, Gupta S, Hattangadi J, Mell LK, Heestand G, Fanta P, Ramamoorthy S, Le Q, Murphy J. Racial disparity in consultation, treatment, and the impact on survival in metastatic colorectal cancer. J Natl Cancer Inst 2013;105:1814-20.

Murphy JD, Nelson LM, Chang DT, Mell LK, Le QT. Patterns of care in palliative radiotherapy: a population-based study. J Oncol Pract 2013; 9:e220-7

Mell LK, Carmona R, Gulaya S, Lu T, Wu J, Saenz CC, Vaida F. Cause-specific effects of radiotherapy and lymphadenectomy in stage I-II endometrial cancer: a population-based study. J Natl Cancer Inst 2013;105:1656-66

Zakeri K, Rose BS, Gulaya S, D’Amico AV, Mell LK. Competing event risk stratification may improve the design and efficiency of clinical trials: secondary analysis of SWOG 8794. Cont Clin Trials 2013;34:74‑9.

Song S, Rudra S, Hasselle MD, Dorn PL, Mell LK, et al. The effect of treatment time in locally advanced cervical cancer in the era of concurrent chemoradiation. Cancer 2013;119:325-31.

Mell LK, Lau SK, Rose BS, Jeong JH. Reporting of cause-specific treatment effects in cancer clinical trials: a systematic review. Cont Clin Trials 2012;33:920-4.

Devisetty K, Wong S, Mell LK. How does TPF improve survival over PF? Lancet Oncol 2011;12:419-420.

Rose BS, Jeong JH, Nath SK, Lu S, Mell LK. Population-based study of competing mortality in head and neck cancer. J Clin Oncol. 2011;29:3503-9.

     See Accompanying Editorial: Manola JB, Gray RJ. When bad things happen to good studies. J Clin Oncol 2011;29:3497-9.

Nichols MA, Mell LK, Hasselle MD, et al. Outcomes in black patients with early breast cancer treated with breast conservation therapy. Int J Radiat Oncol Biol Phys. 2011;79:392-9.

Mell LK, Jeong JH, Nichols MA, et al. Predictors of competing mortality in early breast cancer.  Cancer. 2010;116:5365-73.Ÿ Mell LK, Jeong JH. Pitfalls of using composite primary endpoints in the presence of competing risks. J Clin Oncol. 2010;28:4297-4299.

Mell LK, Dignam JJ, Salama JK, et al. Predictors of competing mortality in advanced head and neck cancer. J Clin Oncol. 2010;28:15-20.

Salama JK, Mell LK, Schomas DA, et al. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience. J Clin Oncol. 2007;25:4581-6.

Mell LK, Weichselbaum RR. More on cetuximab in head and neck cancer. New England Journal of Medicine 2007; 37:2201-3.

Kochanski JD, Mell LK, Roeske JC, Mundt AJ. Intensity-modulated radiation therapy in gynecologic malignancies: current status and future directions. Clin Adv Hematol Oncol. 2006;4:379-86.

Mell LK, Mundt AJ. Radiotherapy in the elderly. Geriatrics and Aging. 2005;8:50-56.Ÿ Mell LK, Mundt AJ. Radiation therapy in the elderly. Cancer J. 2005;11:495-505.

Mell LK, Meyer JJ, Tretiakova M, et al. Prognostic significance of decreased E-Cadherin protein expression in pathologic stage I-III endometrial cancer. Clin Cancer Res. 2004;10:5546-5553.

Mell LK, Mundt AJ.  Concern with “Is there a survival benefit to adjuvant radiotherapy in high-risk surgical stage I endometrial cancer?”  Gynecologic Oncology 2003; 90:499. 

 

Books and Book Chapters

Seibert TM, Simpson DR, Yashar CM, Mell LK, Mundt AJ. Innovations in Radiotherapy of Gynecologic Cancers. In: Gynecologic Cancers: A Multidisciplinary Approach to Diagnosis and Management, Odunsi K, Pejovic T (eds.) Demos Medical Publishing, New York, NY, 2013. pp. 225–232.

Costello C, Mell LK. Lymphoma. In: Clinical Radiation Oncology. Small W (ed.). Wiley. In press.

Mundt AJ, Mell LK, Yashar CM. Gynecologic malignancies. In: Treatment Planning in Radiation Oncology. Khan FM (ed.). Lippincott, Philadelphia. In press.

Mundt AJ, Yashar CM, Mell LK. Vulvar cancer. In: Target Volume Delineation and Field Setup. Lee NY, Lu JJ (eds.) Springer-Verlag, Berlin-Heidelberg, 2013. pp. 207-212.

Mundt AJ, Yashar CM, Mell LK. Vaginal cancer. In: Target Volume Delineation and Field Setup. Lee NY, Lu JJ (eds.) Springer-Verlag, Berlin-Heidelberg, 2013. pp. 201-206

Mundt AJ, Yashar CM, Mell LK. Ovarian cancer. In: Target Volume Delineation and Field Setup. Lee NY, Lu JJ (eds.) Springer-Verlag, Berlin-Heidelberg, 2013. pp. 195-200.

Mundt AJ, Yashar CM, Mell LK. Endometrial cancer. In: Target Volume Delineation and Field Setup. Lee NY, Lu JJ (eds.) Springer-Verlag, Berlin-Heidelberg, 2013. pp. 187-194.

Mundt AJ, Yashar CM, Mell LK. Cervical cancer. In: Target Volume Delineation and Field Setup. Lee NY, Lu JJ (eds.) Springer-Verlag, Berlin-Heidelberg, 2013. pp. 177-86.

Mell LK, Yashar CM, Nichols MA. Use of pelvic radiotherapy in intermediate-risk endometrial cancer. In: Radiation Oncology. Difficult Cases and Practical Management. Small W, Williams TR, Donnelly ED (eds.). Demos Medical Publishing, New York, NY, 2013. pp. 98-104.

Jensen LG, Mell LK. Salivary gland cancer. In: Encyclopedia of Radiation Oncology. Brady LW, Yaeger TE (eds.). Springer-Verlag, Berlin, 2013, pp. 771-75.

Jensen LG, Rose BS, Mell LK, Mundt AJ. Bone marrow toxicity in cancer treatment. In: Encyclopedia of Radiation Oncology. Brady LW, Yaeger TE (eds.). Springer-Verlag, Berlin, 2013, pp. 41-43.

Mell LK, Song WY, Pawlicki T, Mundt AJ. Image-guided radiation therapy. In: Principles and practice of radiation oncology. Wazer D (eds), Lippincott, Philadelphia, 2012. pp. 246 76.

Gynecologic Cancer. Mundt AJ, Yashar CM, Mell LK (eds). Demos Medical. New York, NY. 2011.

Jensen LG, Mundt AJ, Mell LK. Intensity-modulated radiotherapy for gynecologic malignancies. In: Radiation Medicine Rounds. Mundt AJ, Mell LK, Yashar CM (eds.). Demos Medical Publishing LLC, 2011. pp. 341-56.

Simpson DR, Nath SK, Rose BS, Mell LK, et al. Adaptive IGRT: a physician’s perspective. In: Image-guided radiation therapy: a clinical perspective. Mundt AJ, Roeske JC (eds). Ontario: BC Decker, 2011, pp. 570-94.

Mell LK, Song WY. KV CBCT-guided IMRT using the Varian Trilogy system in a patient with Non-Hodgkin’s lymphoma. In: Image-guided radiation therapy: a clinical perspective. Mundt AJ, Roeske JC (eds). Ontario: BC Decker, 2011, pp. 494-7.

Liang Y, Mell LK. Fat fraction MR and 18F-FDG PET-guided active bone marrow delineation in a patient with cervical cancer treated with bone marrow sparing IMRT. In: Image-guided radiation therapy: a clinical perspective. Mundt AJ, Roeske JC (eds). Ontario: BC Decker, 2011, pp. 443-6.

Mell LK, Roeske JC, Mundt AJ. Gynecologic tumors: overview. In: Image-guided radiation therapy: a clinical perspective. Mundt AJ, Roeske JC (eds). Ontario: BC Decker, 2011, pp. 411-29.

Jiang SB, Mell LK, Sandhu AP. Lung cancer. In: Image guided radiation therapy. Xing L, Timmerman R (eds.). Lippincott Williams & Wilkins, Philadelphia, 2009. pp. 191 201.

Mell LK, Haslam JJ, Roeske JC, Mundt AJ. Gynecologic malignancies. In: Image guided radiation therapy. Xing L, Timmerman R (eds.). Lippincott Williams & Wilkins, Philadelphia, 2009. pp. 255-263.

Mell LK, Pawlicki T, Jiang S, Mundt AJ. Image-guided radiation therapy. In: Principles and practice of radiation oncology. Perez C, Halperin E (eds), Lippincott, Philadelphia, 2007. pp 263-298.

Mell LK, Mundt AJ.  Radiation therapy in the older cancer patient. In: Multidisciplinary treatment and management of cancer in the elderly. Muss HB, Johnson KA, Hunter CP (eds). Marcel Dekker, 2005. pp 57-99.

Mell LK, Roeske JC, Mehta N, Mundt AJ. Gynecologic cancer: overview. In: Intensity modulated radiation therapy: a clinical perspective. Mundt AJ, Roeske JC (eds). Ontario: BC Decker, 2004. pp 492‑505. 

 

Pediatrics and Infectious Disease

Mell LK, Davis RL, Owens D. Association between streptococcal infection and obsessive-compulsive disorder, Tourette’s syndrome, and tic disorder. Pediatrics. 2005;116:56-60.

Mell LK, Ogren DS, Davis RL, et al. Compliance with national immunization guidelines for children younger than 2 years, 1996-99. Pediatrics. 2005;115:461-467.

Davis RL, Coplan P, Mell L, Black S, Shinefield H, Lewis E. Impact of the introduction of a combined Haemophilus B conjugate vaccine and hepatitis B recombinant vaccine on vaccine coverage rates in a large West Coast health maintenance organization. Pediatr Infect Dis J. 2003;22:657-8.

Mell LK, Davis RL, Mullooly JP, et al.  Polio extraimmunization in children less than two years old following changes in immunization recommendations. Pediatrics. 2003;111:296 301.Ÿ Guevara J, Lozano P, Wickizer T, Mell L, Gephart H. Psychotropic medication use in a population of children who have Attention Deficit Hyperactivity Disorder. Pediatrics. 2002;109:733-9.  Ÿ Guevara J, Lozano P, Wickizer T, Mell L, Gephart H. Utilization and cost of health care services for children with Attention Deficit Hyperactivity Disorder. Pediatrics. 2001;108:71 78.

Lieu TA, Davis RL, Capra AM, Mell LK, et al. Variation in clinician recommendations for multiple injections during adoption of inactivated polio vaccine. Pediatrics. 2001;107:e49.

Davis RL, Lieu TA, Mell LK, et al.  Impact of the change in polio vaccination schedule on immunization coverage rates.  A study in two large health maintenance organizations. Pediatrics. 2001;107:671-6.

Christakis DA, Mell L, Koepsell TD, Zimmerman FJ, Connell FA.  Association of lower continuity of care with greater risk of emergency department use and hospitalization in children.  Pediatrics. 2001;107:524-9.  

Christakis DA, Mell L, Wright JA, Davis R, Connell FA. The association between greater continuity of care and timely measles-mumps-rubella vaccination. Am J Public Health. 2000;90:962-5.

Davis RL, Mell LK, Zavitkovsky A, Thompson RS. Impact of the sequential IPV/OPV schedule on vaccination coverage levels - United States, 1997. JAMA. 1999;281:223-4.

Davis RL, Mell LK, Zavitkovsky A, et al.  Impact of the sequential IPV/OPV schedule on vaccination coverage levels in the United States, 1997.  Morbidity and Mortality Weekly Report. 1998;47:1017-9.